Aurobindo Pharma Ltd.'s net profit saw a net profit up 33% to Rs 1,126 crore as per its financial results for the second quarter of fiscal 2026, according to an exchange filing from the company on Wednesday. The pharmaceutical company saw a profit of Rs 848 crore for the same period in the previous financial year.
The firm declared an interim dividend of Rs 7 per share. The record date to payout the divivdend amount to the eligible shareholders is Nov. 11. The amount will be disbursed on or before Nov. 20, 2026.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
ALSO READ: Emcure Pharmaceuticals Share Price Hits 10% Upper Circuit To Touch 52-Week High; Should You Buy?
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
The revenue rose 24% to Rs 10,263 crore, compared to Rs 8,286 crore in the year-ago period. The firm's earnings before interest, taxes, depreciation, and amortisation (Ebitda) climbed 28.5% to Rs 2,156 crore, compared to Rs 1,678 crore in the preceding fiscal. Its Ebitda margin widened to 21% from 20.3% in the year-ago period.
Aurobindo Pharma Q2 Highlights (Cons, YoY)
- Net Profit Up 32.7% At Rs 1,126 crore Vs Rs 848 crore
- Revenue Up 23.9% At Rs 10,263 crore Vs Rs 8,286 crore
- Ebitda Up 28.5% At Rs 2,156 crore Vs Rs 1,678 crore
- Ebitda Margin At 21% Vs 20.3% YoY
- To Pay Interim Dividend Of Rs 7/Share
Aurobindo Pharma Share Price Movement
Shares of Aurobindo Pharma Ltd. saw a 0.062% uptick to settle at Rs 1,705 at the end of the day's trade, compared to a 0.63% uptick of the NSE Nifty 50.
The stock opened at Rs 1,698.00, compared to its previous close of Rs 1,694.50. During today's trading session, Aurobindo Pharma Ltd. share price moved in the range of Rs 1,691.00 to Rs 1,724.60.
ALSO READ: Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%
Looking at its last 52-week performance, the stock has touched a low of Rs 1,106.00 and a high of Rs 1,740.00. On the performance front, Aurobindo Pharma Ltd. share price is up 48.38% on a year-on-year basis.
The market capitalization of Aurobindo Pharma Ltd. is Rs 65,380.84 crore, with a P/E ratio of 27.16.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
